Clinical studies recruiting near Bridgeport

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Pfizer · NCT07144280 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · CG Oncology, Inc. · NCT06567743 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · United Hospital Center · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · United Hospital Center · Alliance for Clinical Trials in Oncology · NCT06876714 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Phase N/A · Abbott Medical Devices · NCT03876054 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · National Cancer Institute (NCI) · NCT04269902 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · New England Research Associates - Bridgeport /ID# 262184 · AbbVie · NCT06345339 Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Phase 2 · Dendreon · NCT06134232 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · United Hospital Center · Alliance for Clinical Trials in Oncology · NCT04242095 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Comp
Phase 3 · Research Site · AstraZeneca · NCT07662044 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · National Cancer Institute (NCI) · NCT05256225 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Bridgeport Hospital · Novartis Pharmaceuticals · NCT07517263 Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
NA · Eastern Cooperative Oncology Group · NCT05108298 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · NRG Oncology · NCT04852887 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 SORE Study: Sitz Baths After Urogynecologic Reconstruction
NA · Bridgeport Hospital · Yale University · NCT07215780 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Alliance for Clinical Trials in Oncology · NCT05677490 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · United Hospital Center · National Cancer Institute (NCI) · NCT07198074 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · National Cancer Institute (NCI) · NCT06058377 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · New England Research Associates, LLC · Eli Lilly and Company · NCT07282600 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · SWOG Cancer Research Network · NCT04511013 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · United Hospital Center · NRG Oncology · NCT05080673 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · United Hospital Center · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Hartford HealthCare - Saint Vincent's Medical Center · National Cancer Institute (NCI) · NCT05987241 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · New England Research Associates, LLC · Eli Lilly and Company · NCT07392190 Exercise Intervention and Immunodeficiency
NA · Yale University · NCT07698197 Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
NA · MedtronicNeuro · NCT07456865

Look up another city

Look up another condition